Yibing Qyang
Works at
Professor
Sources: reporter.nih.gov
Grants and prizes
National Heart, Lung, and Blood Institute
R01, Tissue-Engineered Arteriovenous Grafts from Human Induced Pluripotent Stem Cells, R01HL181493, 2026–2030, 3 Sept 2026
National Institute of Allergy and Infectious Diseases
R21, Preclinical Pluripotent Stem Cell Investigation for Vascular Therapeutics, R21AI194864, 2026–2028, 11 Jun 2026
National Heart, Lung, and Blood Institute
R01, Development of HLA engineered universal vascular grafts from human iPSCs, R01HL155411, 2021–2025, 21 Jul 2024
National Heart, Lung, and Blood Institute
R01, Readily Available Stem Cell-Based Vascular Grafts for Emergent Surgical Care, R01HL150352, 2020–2025, 11 Jul 2023
Sources: reporter.nih.gov